Article info

Download PDFPDF
Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations

Authors

  • Hardeep Singh Mudhar National Specialist Ophthalmic Pathology Service (NSOPS), Department of Histopathology, Royal Hallamshire Hospital, Sheffield, UK PubMed articlesGoogle scholar articles
  • Rachel Doherty Academic Unit of Ophthalmology & Orthoptics, Department of Oncology, CR-UK/YCR Sheffield Cancer Research Centre, The Medical School, The University of Sheffield, Sheffield, UK PubMed articlesGoogle scholar articles
  • Abdulazeez Salawu Academic Unit of Ophthalmology & Orthoptics, Department of Oncology, CR-UK/YCR Sheffield Cancer Research Centre, The Medical School, The University of Sheffield, Sheffield, UK PubMed articlesGoogle scholar articles
  • Karen Sisley Academic Unit of Ophthalmology & Orthoptics, Department of Oncology, CR-UK/YCR Sheffield Cancer Research Centre, The Medical School, The University of Sheffield, Sheffield, UK PubMed articlesGoogle scholar articles
  • Ian G Rennie Academic Unit of Ophthalmology & Orthoptics, Department of Oncology, CR-UK/YCR Sheffield Cancer Research Centre, The Medical School, The University of Sheffield, Sheffield, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Hardeep Singh Mudhar, National Specialist Ophthalmic Pathology Service (NSOPS), Department of Histopathology, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK; hardeep.mudhar{at}sth.nhs.uk
View Full Text

Citation

Mudhar HS, Doherty R, Salawu A, et al
Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations

Publication history

  • Received February 18, 2013
  • Revised April 3, 2013
  • Accepted April 7, 2013
  • First published May 17, 2013.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.